Results 91 to 100 of about 21,008,117 (351)

ELISA test for tuberculosis.

open access: yesIndian journal of medical sciences, 1994
The Elisa test for diagnosis of tuberculosis using highly purified A 60 antigen extracted from mycobacteria was developed by Anda Biologicals, France, during the late 1980s. It is claimed to have about 95% sensitivity and specificity. Both IgG and IgM antibodies can be separately tested.
V G, Daftary, D D, Banker, G V, Daftary
openaire   +1 more source

IgG Avidity ELISA Test for Diagnosis of Acute Toxoplasmosis in Humans

open access: yesKorean Journal of Parasitology, 2012
Serum samples, 100 in the total number, were collected from different laboratories in Tehran, Iran and tested for anti-Toxoplasma specific IgG and IgM antibodies using indirect immunofluorescent antibody test (IFAT).
A. Rahbari   +4 more
semanticscholar   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

open access: yesMolecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice   +16 more
wiley   +1 more source

Comparison between ELISA and the Microscopic Agglutination Test for the Diagnosis of Bovine Leptospirosis

open access: yesRevue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 2008
An indirect enzyme-linked immunosorbent assay (ELISA) was compared with the microscopic agglutination test (MAT) for the diagnosis of bovine leptospirosis. A total of 170 random bovine serum samples were collected from cattle farms in Malaysia. The serum
I. M. El Jalii
doaj   +1 more source

The place and role of serologic methods in detecting Helicobacter pylori infection [PDF]

open access: yes, 2006
The aim of the study was to determine the place and role of serologic methods in detecting Helicobacter pylori (H. pylori) infection, on the basis of estimated enzyme-linked immunosorbent assay (ELISA) and complement fixation test (CFT) sensitivity and ...
Dominis, Mara   +4 more
core  

The LISA pathfinder mission [PDF]

open access: yes, 2015
ISA Pathfinder (LPF), the second of the European Space Agency's Small Missions for Advanced Research in Technology (SMART), is a dedicated technology validation mission for future spaceborne gravitational wave detectors, such as the proposed eLISA ...
Armano, M   +89 more
core   +3 more sources

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

A serological survey of eight infectious diseases in a population of free ranging deer (Cervus timorensis russa) in Mauritius [PDF]

open access: yes, 2009
Rusa deer (Cervus timorensis russa) is the most important red meat production of Mauritius. More than 70.000 heads are exploited annually for 440 tones of venison.
Jaumally, Mahmad Reshad   +3 more
core  

Laboratory evaluation of a rapid IgG4 antibody test (BLF Rapid™) for bancroftian filariasis [PDF]

open access: yes, 2018
At the end phase of the Global Programme to Eliminate Lymphatic Filariasis, antibody testing may have a role in decision-making for bancroftian filariasis–endemic areas.
Babu, Subash   +7 more
core   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy